Share Price and Basic Stock Data
Last Updated: December 9, 2025, 8:22 pm
| PEG Ratio | -4.19 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
DE Nora India Ltd operates in the niche segment of graphite electrodes, catering primarily to the steel and aluminum industries. The company’s recent revenue performance has shown considerable volatility. For instance, sales surged to ₹27.63 Cr in March 2023, a significant jump from ₹19.19 Cr in December 2022. However, the subsequent quarter saw a sharp decline to ₹9.14 Cr in June 2023, raising concerns about demand stability. The latest figures indicate a rebound in sales, with ₹19.08 Cr reported for September 2023 and a forecast of ₹29.40 Cr in December 2023. Over the trailing twelve months (TTM), revenue stood at ₹97.79 Cr, highlighting fluctuations that could be indicative of seasonal demand or operational challenges. The company’s ability to navigate these revenue cycles will be crucial for maintaining investor confidence.
Profitability and Efficiency Metrics
Profitability metrics for DE Nora India reflect a mixed performance. The operating profit margin (OPM) peaked at an impressive 55.81% in March 2023 but has since fluctuated dramatically, dipping to -2.30% in June 2023. This volatility raises questions about cost management and operational efficiency. Net profit also mirrored this trend, with a high of ₹12.32 Cr in March 2023, before declining to ₹0.52 Cr in June 2023. The company reported a trailing twelve-month net profit of ₹2.06 Cr, translating to a P/E ratio of 136, which appears stretched when compared to industry norms. Additionally, the return on equity (ROE) and return on capital employed (ROCE) are at 1.84% and 0.88%, respectively, both of which raise red flags about overall efficiency and asset utilization.
Balance Sheet Strength and Financial Ratios
DE Nora India boasts a robust balance sheet, characterized by zero borrowings, which positions the company favorably in terms of financial risk. The reserves have grown steadily, reaching ₹122 Cr, reflecting prudent financial management. The current ratio at 4.97 and quick ratio at 3.54 indicate that the company is well-positioned to meet short-term obligations. However, with a price-to-book value ratio of 3.01x, the stock may appear overvalued relative to its net asset value, suggesting that investors are paying a premium for future growth potential. The cash conversion cycle, reported at 402.82 days, indicates potential inefficiencies in managing working capital, which could affect liquidity if not addressed. While the financials are generally stable, the efficiency metrics require close monitoring.
Shareholding Pattern and Investor Confidence
The shareholding structure of DE Nora India reveals a significant promoter stake of 53.68%, which may instill confidence among investors regarding long-term strategic direction. However, foreign institutional investors (FIIs) hold a mere 0.01%, while domestic institutional investors (DIIs) account for only 0.22%. This low institutional interest could be a concern, as it may limit the stock’s liquidity and market perception. The public holds 46.10% of shares, with the number of shareholders increasing from 8,888 in December 2022 to 15,024 as of March 2025. This growth in retail participation is a positive sign, suggesting that the stock is gaining traction among smaller investors. However, the lack of significant institutional backing could imply that large investors are wary of the company’s recent performance issues.
Outlook, Risks, and Final Insight
Looking ahead, DE Nora India faces a dual-edged sword of opportunity and risk. On one hand, the resurgence in sales figures and a solid balance sheet provides a foundation for potential growth. On the other hand, the volatility in profitability and the stretched valuations present significant risks. Investors should be cautious; the company’s ability to stabilize its operational performance amid fluctuating demand will be critical. Moreover, the low institutional interest could hinder stock performance in a volatile market. For retail investors, keeping an eye on quarterly performance and operational efficiency will be essential. The current landscape suggests that while there are growth prospects, the inherent risks warrant a careful and informed approach when considering an investment in DE Nora India.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of DE Nora India Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HEG Ltd | 10,380 Cr. | 537 | 622/331 | 40.2 | 242 | 0.34 % | 3.96 % | 2.59 % | 2.00 |
| Graphite India Ltd | 10,575 Cr. | 541 | 652/366 | 43.9 | 301 | 2.03 % | 10.1 % | 8.00 % | 2.00 |
| DE Nora India Ltd | 367 Cr. | 691 | 1,458/651 | 139 | 240 | 0.00 % | 0.88 % | 1.84 % | 10.0 |
| Industry Average | 7,107.33 Cr | 589.67 | 74.37 | 261.00 | 0.79% | 4.98% | 4.14% | 4.67 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 12.38 | 14.37 | 19.19 | 27.63 | 9.14 | 19.08 | 29.40 | 16.18 | 12.76 | 18.13 | 17.56 | 20.13 | 41.97 |
| Expenses | 10.09 | 12.61 | 13.99 | 12.21 | 9.35 | 11.44 | 21.91 | 9.93 | 9.82 | 14.92 | 28.95 | 16.30 | 39.53 |
| Operating Profit | 2.29 | 1.76 | 5.20 | 15.42 | -0.21 | 7.64 | 7.49 | 6.25 | 2.94 | 3.21 | -11.39 | 3.83 | 2.44 |
| OPM % | 18.50% | 12.25% | 27.10% | 55.81% | -2.30% | 40.04% | 25.48% | 38.63% | 23.04% | 17.71% | -64.86% | 19.03% | 5.81% |
| Other Income | 0.47 | 0.61 | 1.49 | 1.29 | 1.16 | 1.14 | 1.19 | 1.71 | 1.34 | 1.65 | 1.50 | 1.37 | 2.36 |
| Interest | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.64 | 0.24 | 0.25 | 0.24 | 0.25 | 0.25 | 0.29 | 0.35 | 0.40 | 0.42 | 0.44 | 0.45 | 0.46 |
| Profit before tax | 2.11 | 2.13 | 6.44 | 16.47 | 0.70 | 8.53 | 8.39 | 7.61 | 3.88 | 4.44 | -10.33 | 4.75 | 4.34 |
| Tax % | 25.59% | 26.29% | 25.31% | 25.14% | 25.71% | 25.56% | 22.77% | 25.76% | 25.77% | 26.35% | -24.30% | 29.68% | 25.12% |
| Net Profit | 1.57 | 1.58 | 4.81 | 12.32 | 0.52 | 6.35 | 6.48 | 5.66 | 2.88 | 3.28 | -7.81 | 3.34 | 3.25 |
| EPS in Rs | 2.96 | 2.98 | 9.06 | 23.21 | 0.98 | 11.96 | 12.21 | 10.66 | 5.43 | 6.18 | -14.71 | 6.29 | 6.12 |
Last Updated: August 1, 2025, 10:15 pm
Below is a detailed analysis of the quarterly data for DE Nora India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 41.97 Cr.. The value appears strong and on an upward trend. It has increased from 20.13 Cr. (Mar 2025) to 41.97 Cr., marking an increase of 21.84 Cr..
- For Expenses, as of Jun 2025, the value is 39.53 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 16.30 Cr. (Mar 2025) to 39.53 Cr., marking an increase of 23.23 Cr..
- For Operating Profit, as of Jun 2025, the value is 2.44 Cr.. The value appears to be declining and may need further review. It has decreased from 3.83 Cr. (Mar 2025) to 2.44 Cr., marking a decrease of 1.39 Cr..
- For OPM %, as of Jun 2025, the value is 5.81%. The value appears to be declining and may need further review. It has decreased from 19.03% (Mar 2025) to 5.81%, marking a decrease of 13.22%.
- For Other Income, as of Jun 2025, the value is 2.36 Cr.. The value appears strong and on an upward trend. It has increased from 1.37 Cr. (Mar 2025) to 2.36 Cr., marking an increase of 0.99 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.46 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.45 Cr. (Mar 2025) to 0.46 Cr., marking an increase of 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is 4.34 Cr.. The value appears to be declining and may need further review. It has decreased from 4.75 Cr. (Mar 2025) to 4.34 Cr., marking a decrease of 0.41 Cr..
- For Tax %, as of Jun 2025, the value is 25.12%. The value appears to be improving (decreasing) as expected. It has decreased from 29.68% (Mar 2025) to 25.12%, marking a decrease of 4.56%.
- For Net Profit, as of Jun 2025, the value is 3.25 Cr.. The value appears to be declining and may need further review. It has decreased from 3.34 Cr. (Mar 2025) to 3.25 Cr., marking a decrease of 0.09 Cr..
- For EPS in Rs, as of Jun 2025, the value is 6.12. The value appears to be declining and may need further review. It has decreased from 6.29 (Mar 2025) to 6.12, marking a decrease of 0.17.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:27 am
| Metric | Dec 2013 | Dec 2014 | Mar 2016n n 15m | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 35.81 | 30.52 | 50.83 | 26.67 | 27.03 | 32.78 | 48.23 | 50.54 | 74.17 | 73.58 | 73.80 | 68.58 | 97.79 |
| Expenses | 28.92 | 25.38 | 35.33 | 24.62 | 24.98 | 32.30 | 37.65 | 42.08 | 51.27 | 48.81 | 52.41 | 69.83 | 99.70 |
| Operating Profit | 6.89 | 5.14 | 15.50 | 2.05 | 2.05 | 0.48 | 10.58 | 8.46 | 22.90 | 24.77 | 21.39 | -1.25 | -1.91 |
| OPM % | 19.24% | 16.84% | 30.49% | 7.69% | 7.58% | 1.46% | 21.94% | 16.74% | 30.88% | 33.66% | 28.98% | -1.82% | -1.95% |
| Other Income | 1.08 | 2.24 | 3.77 | 3.31 | 3.16 | 3.99 | 2.43 | 1.78 | 0.96 | 3.83 | 5.16 | 5.86 | 6.88 |
| Interest | 0.34 | 0.16 | 0.12 | 0.06 | 0.01 | 0.12 | 0.06 | 0.06 | 0.23 | 0.08 | 0.18 | 0.15 | 0.00 |
| Depreciation | 0.71 | 1.20 | 1.16 | 0.85 | 2.13 | 2.53 | 2.59 | 2.60 | 2.67 | 1.37 | 1.15 | 1.70 | 1.77 |
| Profit before tax | 6.92 | 6.02 | 17.99 | 4.45 | 3.07 | 1.82 | 10.36 | 7.58 | 20.96 | 27.15 | 25.22 | 2.76 | 3.20 |
| Tax % | 30.92% | 29.40% | 33.41% | 33.03% | 44.95% | 12.64% | 21.53% | 25.46% | 26.29% | 25.30% | 24.62% | 38.41% | |
| Net Profit | 4.78 | 4.25 | 11.98 | 2.98 | 1.69 | 1.59 | 8.13 | 5.65 | 15.45 | 20.28 | 19.01 | 1.69 | 2.06 |
| EPS in Rs | 9.00 | 8.01 | 22.57 | 5.61 | 3.18 | 3.00 | 15.31 | 10.64 | 29.10 | 38.20 | 35.81 | 3.18 | 3.88 |
| Dividend Payout % | 44.44% | 18.74% | 17.73% | 35.64% | 31.42% | 0.00% | 0.00% | 9.40% | 3.44% | 5.24% | 5.59% | 0.00% |
YoY Net Profit Growth
| Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -43.29% | -5.92% | 411.32% | -30.50% | 173.45% | 31.26% | -6.26% | -91.11% |
| Change in YoY Net Profit Growth (%) | 0.00% | 37.37% | 417.24% | -441.83% | 203.96% | -142.19% | -37.52% | -84.85% |
DE Nora India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2017-2018 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 7% |
| 3 Years: | -3% |
| TTM: | 26% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | -23% |
| 3 Years: | -48% |
| TTM: | -90% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 31% |
| 3 Years: | 5% |
| 1 Year: | -48% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 13% |
| 3 Years: | 13% |
| Last Year: | 2% |
Last Updated: September 5, 2025, 2:45 am
Balance Sheet
Last Updated: December 4, 2025, 1:09 am
| Month | Dec 2013 | Dec 2014 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 31 | 34 | 43 | 47 | 47 | 48 | 56 | 62 | 77 | 96 | 114 | 115 | 122 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 12 | 9 | 12 | 12 | 11 | 12 | 13 | 13 | 12 | 14 | 7 | 22 | 48 |
| Total Liabilities | 48 | 49 | 60 | 64 | 63 | 65 | 75 | 80 | 94 | 116 | 127 | 142 | 175 |
| Fixed Assets | 7 | 7 | 7 | 7 | 14 | 12 | 10 | 10 | 7 | 8 | 13 | 15 | 17 |
| CWIP | 1 | 1 | 2 | 7 | 0 | 0 | 1 | 0 | 1 | 2 | 2 | 3 | 1 |
| Investments | 8 | 14 | 19 | 20 | 20 | 14 | 5 | 4 | 23 | 42 | 54 | 52 | 74 |
| Other Assets | 33 | 26 | 32 | 29 | 29 | 40 | 60 | 66 | 62 | 64 | 57 | 73 | 84 |
| Total Assets | 48 | 49 | 60 | 64 | 63 | 65 | 75 | 80 | 94 | 116 | 127 | 142 | 175 |
Below is a detailed analysis of the balance sheet data for DE Nora India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.00 Cr..
- For Reserves, as of Sep 2025, the value is 122.00 Cr.. The value appears strong and on an upward trend. It has increased from 115.00 Cr. (Mar 2025) to 122.00 Cr., marking an increase of 7.00 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 48.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 22.00 Cr. (Mar 2025) to 48.00 Cr., marking an increase of 26.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 175.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 142.00 Cr. (Mar 2025) to 175.00 Cr., marking an increase of 33.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 17.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Mar 2025) to 17.00 Cr., marking an increase of 2.00 Cr..
- For CWIP, as of Sep 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 2.00 Cr..
- For Investments, as of Sep 2025, the value is 74.00 Cr.. The value appears strong and on an upward trend. It has increased from 52.00 Cr. (Mar 2025) to 74.00 Cr., marking an increase of 22.00 Cr..
- For Other Assets, as of Sep 2025, the value is 84.00 Cr.. The value appears strong and on an upward trend. It has increased from 73.00 Cr. (Mar 2025) to 84.00 Cr., marking an increase of 11.00 Cr..
- For Total Assets, as of Sep 2025, the value is 175.00 Cr.. The value appears strong and on an upward trend. It has increased from 142.00 Cr. (Mar 2025) to 175.00 Cr., marking an increase of 33.00 Cr..
Notably, the Reserves (122.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Dec 2013 | Dec 2014 | Mar 2016n n 15m | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 6.89 | 5.14 | 15.50 | 2.05 | 2.05 | 0.48 | 9.58 | 8.46 | 22.90 | 24.77 | 21.39 | -1.25 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Dec 2013 | Dec 2014 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 131.38 | 139.09 | 74.97 | 81.84 | 64.14 | 61.24 | 97.25 | 78.79 | 57.97 | 84.48 | 50.55 | 71.42 |
| Inventory Days | 298.87 | 229.19 | 130.01 | 197.82 | 398.23 | 516.42 | 471.41 | 272.94 | 288.42 | 397.03 | 401.25 | 412.83 |
| Days Payable | 69.54 | 66.71 | 79.72 | 113.65 | 263.55 | 181.89 | 82.99 | 46.94 | 36.90 | 90.83 | 51.25 | 81.43 |
| Cash Conversion Cycle | 360.72 | 301.58 | 125.26 | 166.01 | 198.83 | 395.77 | 485.67 | 304.79 | 309.49 | 390.68 | 400.55 | 402.82 |
| Working Capital Days | 140.56 | 144.35 | 45.02 | 13.96 | 48.34 | 135.73 | 218.41 | 155.56 | 131.98 | 163.85 | 157.28 | 127.79 |
| ROCE % | 20.94% | 16.46% | 41.15% | 8.95% | 6.10% | 3.67% | 17.97% | 11.92% | 28.43% | 29.67% | 21.96% | 0.88% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 3.19 | 35.80 | 38.19 | 29.10 | 10.64 |
| Diluted EPS (Rs.) | 3.19 | 35.80 | 38.19 | 29.10 | 10.64 |
| Cash EPS (Rs.) | 6.39 | 37.96 | 40.77 | 34.13 | 15.54 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 226.33 | 225.46 | 191.53 | 154.24 | 126.16 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 226.33 | 225.46 | 191.53 | 154.24 | 126.16 |
| Dividend / Share (Rs.) | 0.00 | 2.00 | 2.00 | 1.00 | 1.00 |
| Revenue From Operations / Share (Rs.) | 129.19 | 139.01 | 138.60 | 139.71 | 95.20 |
| PBDIT / Share (Rs.) | 8.39 | 49.67 | 53.75 | 44.79 | 19.17 |
| PBIT / Share (Rs.) | 5.19 | 47.52 | 51.17 | 39.76 | 14.27 |
| PBT / Share (Rs.) | 5.19 | 47.52 | 51.15 | 39.48 | 14.27 |
| Net Profit / Share (Rs.) | 3.19 | 35.80 | 38.19 | 29.10 | 10.63 |
| PBDIT Margin (%) | 6.49 | 35.73 | 38.78 | 32.05 | 20.13 |
| PBIT Margin (%) | 4.01 | 34.18 | 36.92 | 28.45 | 14.98 |
| PBT Margin (%) | 4.01 | 34.18 | 36.90 | 28.25 | 14.98 |
| Net Profit Margin (%) | 2.46 | 25.75 | 27.55 | 20.83 | 11.17 |
| Return on Networth / Equity (%) | 1.40 | 15.88 | 19.94 | 18.86 | 8.42 |
| Return on Capital Employeed (%) | 2.28 | 21.07 | 26.61 | 25.77 | 11.30 |
| Return On Assets (%) | 1.18 | 15.00 | 17.53 | 16.49 | 7.09 |
| Asset Turnover Ratio (%) | 0.50 | 0.60 | 0.70 | 0.85 | 0.65 |
| Current Ratio (X) | 4.97 | 14.48 | 7.61 | 7.06 | 5.38 |
| Quick Ratio (X) | 3.54 | 10.52 | 5.50 | 5.03 | 3.84 |
| Inventory Turnover Ratio (X) | 2.33 | 0.72 | 1.02 | 1.27 | 1.15 |
| Dividend Payout Ratio (NP) (%) | 62.71 | 5.58 | 2.61 | 3.43 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 31.28 | 5.26 | 2.45 | 2.92 | 0.00 |
| Earning Retention Ratio (%) | 37.29 | 94.42 | 97.39 | 96.57 | 0.00 |
| Cash Earning Retention Ratio (%) | 68.72 | 94.74 | 97.55 | 97.08 | 0.00 |
| Interest Coverage Ratio (X) | 0.00 | 0.00 | 2194.98 | 159.15 | 0.00 |
| Interest Coverage Ratio (Post Tax) (X) | 0.00 | 0.00 | 1560.69 | 104.42 | 0.00 |
| Enterprise Value (Cr.) | 350.13 | 858.53 | 434.79 | 190.91 | 103.33 |
| EV / Net Operating Revenue (X) | 5.11 | 11.63 | 5.91 | 2.57 | 2.04 |
| EV / EBITDA (X) | 78.56 | 32.56 | 15.24 | 8.03 | 10.15 |
| MarketCap / Net Operating Revenue (X) | 5.27 | 11.74 | 6.12 | 2.86 | 2.64 |
| Retention Ratios (%) | 37.28 | 94.41 | 97.38 | 96.56 | 0.00 |
| Price / BV (X) | 3.01 | 7.24 | 4.43 | 2.59 | 1.99 |
| Price / Net Operating Revenue (X) | 5.27 | 11.74 | 6.12 | 2.86 | 2.64 |
| EarningsYield | 0.00 | 0.02 | 0.04 | 0.07 | 0.04 |
After reviewing the key financial ratios for DE Nora India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 3.19. This value is below the healthy minimum of 5. It has decreased from 35.80 (Mar 24) to 3.19, marking a decrease of 32.61.
- For Diluted EPS (Rs.), as of Mar 25, the value is 3.19. This value is below the healthy minimum of 5. It has decreased from 35.80 (Mar 24) to 3.19, marking a decrease of 32.61.
- For Cash EPS (Rs.), as of Mar 25, the value is 6.39. This value is within the healthy range. It has decreased from 37.96 (Mar 24) to 6.39, marking a decrease of 31.57.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 226.33. It has increased from 225.46 (Mar 24) to 226.33, marking an increase of 0.87.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 226.33. It has increased from 225.46 (Mar 24) to 226.33, marking an increase of 0.87.
- For Dividend / Share (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 2.00 (Mar 24) to 0.00, marking a decrease of 2.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 129.19. It has decreased from 139.01 (Mar 24) to 129.19, marking a decrease of 9.82.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 8.39. This value is within the healthy range. It has decreased from 49.67 (Mar 24) to 8.39, marking a decrease of 41.28.
- For PBIT / Share (Rs.), as of Mar 25, the value is 5.19. This value is within the healthy range. It has decreased from 47.52 (Mar 24) to 5.19, marking a decrease of 42.33.
- For PBT / Share (Rs.), as of Mar 25, the value is 5.19. This value is within the healthy range. It has decreased from 47.52 (Mar 24) to 5.19, marking a decrease of 42.33.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 3.19. This value is within the healthy range. It has decreased from 35.80 (Mar 24) to 3.19, marking a decrease of 32.61.
- For PBDIT Margin (%), as of Mar 25, the value is 6.49. This value is below the healthy minimum of 10. It has decreased from 35.73 (Mar 24) to 6.49, marking a decrease of 29.24.
- For PBIT Margin (%), as of Mar 25, the value is 4.01. This value is below the healthy minimum of 10. It has decreased from 34.18 (Mar 24) to 4.01, marking a decrease of 30.17.
- For PBT Margin (%), as of Mar 25, the value is 4.01. This value is below the healthy minimum of 10. It has decreased from 34.18 (Mar 24) to 4.01, marking a decrease of 30.17.
- For Net Profit Margin (%), as of Mar 25, the value is 2.46. This value is below the healthy minimum of 5. It has decreased from 25.75 (Mar 24) to 2.46, marking a decrease of 23.29.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.40. This value is below the healthy minimum of 15. It has decreased from 15.88 (Mar 24) to 1.40, marking a decrease of 14.48.
- For Return on Capital Employeed (%), as of Mar 25, the value is 2.28. This value is below the healthy minimum of 10. It has decreased from 21.07 (Mar 24) to 2.28, marking a decrease of 18.79.
- For Return On Assets (%), as of Mar 25, the value is 1.18. This value is below the healthy minimum of 5. It has decreased from 15.00 (Mar 24) to 1.18, marking a decrease of 13.82.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.50. It has decreased from 0.60 (Mar 24) to 0.50, marking a decrease of 0.10.
- For Current Ratio (X), as of Mar 25, the value is 4.97. This value exceeds the healthy maximum of 3. It has decreased from 14.48 (Mar 24) to 4.97, marking a decrease of 9.51.
- For Quick Ratio (X), as of Mar 25, the value is 3.54. This value exceeds the healthy maximum of 2. It has decreased from 10.52 (Mar 24) to 3.54, marking a decrease of 6.98.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.33. This value is below the healthy minimum of 4. It has increased from 0.72 (Mar 24) to 2.33, marking an increase of 1.61.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 62.71. This value exceeds the healthy maximum of 50. It has increased from 5.58 (Mar 24) to 62.71, marking an increase of 57.13.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 31.28. This value is within the healthy range. It has increased from 5.26 (Mar 24) to 31.28, marking an increase of 26.02.
- For Earning Retention Ratio (%), as of Mar 25, the value is 37.29. This value is below the healthy minimum of 40. It has decreased from 94.42 (Mar 24) to 37.29, marking a decrease of 57.13.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 68.72. This value is within the healthy range. It has decreased from 94.74 (Mar 24) to 68.72, marking a decrease of 26.02.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 3. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 3. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Enterprise Value (Cr.), as of Mar 25, the value is 350.13. It has decreased from 858.53 (Mar 24) to 350.13, marking a decrease of 508.40.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 5.11. This value exceeds the healthy maximum of 3. It has decreased from 11.63 (Mar 24) to 5.11, marking a decrease of 6.52.
- For EV / EBITDA (X), as of Mar 25, the value is 78.56. This value exceeds the healthy maximum of 15. It has increased from 32.56 (Mar 24) to 78.56, marking an increase of 46.00.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.27. This value exceeds the healthy maximum of 3. It has decreased from 11.74 (Mar 24) to 5.27, marking a decrease of 6.47.
- For Retention Ratios (%), as of Mar 25, the value is 37.28. This value is within the healthy range. It has decreased from 94.41 (Mar 24) to 37.28, marking a decrease of 57.13.
- For Price / BV (X), as of Mar 25, the value is 3.01. This value exceeds the healthy maximum of 3. It has decreased from 7.24 (Mar 24) to 3.01, marking a decrease of 4.23.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.27. This value exceeds the healthy maximum of 3. It has decreased from 11.74 (Mar 24) to 5.27, marking a decrease of 6.47.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to 0.00, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in DE Nora India Ltd:
- Net Profit Margin: 2.46%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 2.28% (Industry Average ROCE: 4.98%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.4% (Industry Average ROE: 4.14%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.54
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 139 (Industry average Stock P/E: 74.37)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.46%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Electrodes - Graphite | Plot Nos 184,185 & 189, Kundaim Goa 403115 | info.dni@denora.com https://india.denora.com |
| Management | |
|---|---|
| Name | Position Held |
| Ms. Supriya Banerji | Chairperson & Independent Director |
| Mr. Vinay Chopra | Managing Director |
| Mr. Francesco L�Abbate | Non Executive Director |
| Mr. Robert Scannell | Non Executive Director |
| Mr. Purushottam Mantri | Independent Director |
| Ms. Lalita Correia Afonso | Independent Director |
FAQ
What is the intrinsic value of DE Nora India Ltd?
DE Nora India Ltd's intrinsic value (as of 09 December 2025) is 500.88 which is 27.51% lower the current market price of 691.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 367 Cr. market cap, FY2025-2026 high/low of 1,458/651, reserves of ₹122 Cr, and liabilities of 175 Cr.
What is the Market Cap of DE Nora India Ltd?
The Market Cap of DE Nora India Ltd is 367 Cr..
What is the current Stock Price of DE Nora India Ltd as on 09 December 2025?
The current stock price of DE Nora India Ltd as on 09 December 2025 is 691.
What is the High / Low of DE Nora India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of DE Nora India Ltd stocks is 1,458/651.
What is the Stock P/E of DE Nora India Ltd?
The Stock P/E of DE Nora India Ltd is 139.
What is the Book Value of DE Nora India Ltd?
The Book Value of DE Nora India Ltd is 240.
What is the Dividend Yield of DE Nora India Ltd?
The Dividend Yield of DE Nora India Ltd is 0.00 %.
What is the ROCE of DE Nora India Ltd?
The ROCE of DE Nora India Ltd is 0.88 %.
What is the ROE of DE Nora India Ltd?
The ROE of DE Nora India Ltd is 1.84 %.
What is the Face Value of DE Nora India Ltd?
The Face Value of DE Nora India Ltd is 10.0.